Canonical: https://ownershiptrace.com/13f/companies/748

# Who owns Royalty Pharma plc (RPRX)? Elite investor 13F holders

7 tracked elite investors reported holding Royalty Pharma plc as of 2026-06-30, including Patient Capital Management, Dorsey Asset Management, Renaissance Technologies LLC, D.E. Shaw, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Patient Capital Management](https://ownershiptrace.com/13f/investors/68) | ROYALTY PHARMA PLC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 201785166.00 USD | 3598808.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1854794/0001854794-26-000005-index.html) |
| [Dorsey Asset Management](https://ownershiptrace.com/13f/investors/60) | ROYALTY PHARMA PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 137737525.00 USD | 2456528.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1671657/0001398344-26-014470-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | ROYALTY PHARMA PLC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 108540306.00 USD | 1935800.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | ROYALTY PHARMA PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 29443142.00 USD | 525114.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | ROYALTY PHARMA PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 34243968.00 USD | 610736.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |
| [Torray Funds](https://ownershiptrace.com/13f/investors/76) | ROYALTY PHARMA PLC | SHARE | 2026-06-30 | 2026-07-30 00:00:00 | 33755710.00 USD | 602028.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/98758/0001193125-26-326274-index.html) |
| [Bridgewater Associates](https://ownershiptrace.com/13f/investors/8) | ROYALTY PHARMA PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 12317850.00 USD | 219687.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1350694/0001350694-26-000003-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)